Increased Monocyte Chemotactic Protein-1 Accompanying Pro-Inflammatory Processes are Associated with Progressive Hearing Impairment and Bilateral Disability of Meniere’s Disease

Abstract

<b><i>Background:</i></b> The progression of hearing impairment and the bilateral involvement of Meniere’s disease (MD) may depend on the disease duration and aging. Recent studies reported that MD might involve dysfunction of the microvascular circulation damaged due to inflammatory changes. <b><i>Objectives:</i></b> The aim of this study was to determine that the progress of the MD’s hearing impairment and bilateral disability may be associated with the pathogenesis of several pro-inflammatory processes. <b><i>Patients and Methods:</i></b> We recruited 30 unilateral MD patients (56.8 ± 14.7 years old), 7 bilateral MD patients (65.3 ± 13.9 years old), and 17 age-matched control subjects (53.5 ± 14.4 years old, <i>p</i> > 0.05). We measured the plasma vascular endothelial growth factor (VEGF), plasma interleukin-6 (IL-6), plasma tumor-necrosis factor α (TNFα), and plasma monocyte chemotactic protein-1 (MCP-1). <b><i>Results:</i></b> The bilateral MD group and the unilateral MD group had higher plasma MCP-1 (204.7 ± 41.0 pg/mL and 169.5 ± 32.0 pg/mL) than the control group (149.2 ± 30.7 pg/mL) (<i>p</i> < 0.05). There was no significant difference in plasma TNFα, IL-6, and VEGF among 3 groups (<i>p</i> > 0.05). There was a strong correlation between the plasma MCP-1 and age in MD patients (<i>r</i> = 0.58, <i>p</i> < 0.01); however, no significant correlation between the plasma MCP-1 and age was found in control subjects (<i>p</i> > 0.05). The plasma MCP-1 significantly correlated with the average hearing level of 500, 1,000, 2,000, and 4,000 Hz, and the maximum slow phase eye velocity in caloric test in the better side (<i>p</i> < 0.05). Also, the plasma MCP-1 showed significant positive correlations with the plasma IL-6 (<i>r</i> = 0.49, <i>p</i> < 0.01) and plasma TNFα (<i>r</i> = 0.32, <i>p</i> < 0.05) in MD group. <b><i>Conclusions:</i></b> Our results suggest that the increased plasma MCP-1 accompanying pro-inflammatory processes are associated with the progression of the hearing impairment and the bilateral disability of MD.

Identification of Immune-Related Candidate Biomarkers in Plasma of Patients with Sporadic Vestibular Schwannoma

“…The significant elevation in the levels of the proinflammatory chemokine MCP-1 in VS-PH patients vs. controls, particularly among males, suggests a relationship with poor pre-operative hearing. A similar effect has been found in Meniere’s Disease, where higher plasma MCP-1 values were associated with progression of hearing impairment and bilateral disability ( 32 ). Although the pathophysiological mechanism of MCP-1-mediated hearing loss is unknown, MCP-1 could amplify cochlear inflammation by recruitment of monocytes and macrophages ( 33 ), which may then produce proinflammatory, ototoxic factors such as TNF-α ( 19, 34 ).…”

Exploring the causal relationship between inflatmmatory factors and sensorineural hearing loss:a bidirectional Mendelian randomization study

“…VEGF levels are signi cantly increased in sensorineural deafness, which may be associated to altered inner ear microenvironment and increased drug resistance in sensorineural. 15 SDF1a is a member of the CXL subfamily of chemotactic cytokines, which is widely involved in various pathological processes including in ammation, tumor, viral infection, and cardiovascular. 16 SDF1a plays an important role in cell migration, is closely related to angiogenesis, played chemotaxis by binding to its speci c receptor CXCR-4, and induced neovascularization.…”

Role of Inner Ear Macrophages and Autoimmune/Autoinflammatory Mechanisms in the Pathophysiology of Inner Ear Disease

“…In some patients with Ménière's disease, high levels of IL-1β and TNF-α suggested that it was a chronic inflammatory disorder ( 74 ). In addition, several reports suggested an association between the immune responses caused by Mφs and Ménière's disease ( 75 – 80 ).…”